Your browser doesn't support javascript.
loading
Molecular responses in decitabine- and decitabine/ venetoclax-treated patients with acute myeloid leukemia and myelodysplastic syndromes.
Gruszczynska, Agata; Maiti, Abhishek; Miller, Christopher A; Ramakrishnan, Sai Mukund; Link, Daniel C; Uy, Geoffrey L; Petti, Allegra A; Hayes, Kala; DiNardo, Courtney D; Ravandi, Farhad; Ley, Timothy J; Spencer, David H; Gao, Feng; Konopleva, Marina Y; Welch, John S.
Afiliación
  • Gruszczynska A; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Maiti A; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030.
  • Miller CA; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Ramakrishnan SM; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Link DC; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Uy GL; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Petti AA; Department of Neurosurgery, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Hayes K; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030.
  • DiNardo CD; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030.
  • Ravandi F; Department of Leukemia, MD Anderson Cancer Center, Houston, Texas 77030.
  • Ley TJ; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Spencer DH; Department of Pathology, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Gao F; Department of Surgery, Division of Public Health Sciences, Washington University School of Medicine, St. Louis, Missouri 63110.
  • Konopleva MY; Albert Einstein College of Medicine, Bronx, New York 10461.
  • Welch JS; Department of Medicine, Division of Oncology, Washington University School of Medicine, St. Louis, Missouri 63110; A2 Biotherapeutics, Agoura Hills, California 91301 (work completed while at Washington University). jwelch@a2biotherapeutics.com.
Haematologica ; 109(8): 2653-2659, 2024 08 01.
Article en En | MEDLINE | ID: mdl-38618679
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sulfonamidas / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Compuestos Bicíclicos Heterocíclicos con Puentes / Decitabina Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Sulfonamidas / Síndromes Mielodisplásicos / Leucemia Mieloide Aguda / Protocolos de Quimioterapia Combinada Antineoplásica / Compuestos Bicíclicos Heterocíclicos con Puentes / Decitabina Límite: Adult / Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Haematologica Año: 2024 Tipo del documento: Article